Invention Grant
- Patent Title: Dosage forms containing terbutaline sulphate
-
Application No.: US14433241Application Date: 2013-10-08
-
Publication No.: US09849097B2Publication Date: 2017-12-26
- Inventor: Alain Nhamias , Nasser Beniou
- Applicant: Jagotec AG
- Applicant Address: CH Muttenz
- Assignee: Jagotec AG
- Current Assignee: Jagotec AG
- Current Assignee Address: CH Muttenz
- Agency: Mintz Levin Cohn Ferris Glovsky and Popeo, P.C.
- Agent Muriel Liberto, Esq.
- Priority: GB1218012.1 20121008
- International Application: PCT/EP2013/070900 WO 20131008
- International Announcement: WO2014/056882 WO 20140417
- Main IPC: A61K31/137
- IPC: A61K31/137 ; A61K9/28 ; A61K45/06 ; A61K9/20
Abstract:
A modified release oral dosage form comprising an internal phase containing terbutaline sulphate and a pharmaceutically acceptable excipient, dispersed in an external phase comprising pharmaceutically acceptable excipients.
Public/Granted literature
- US20150250742A1 Dosage Forms Containing Terbutaline Sulphate Public/Granted day:2015-09-10
Information query
